A detailed history of Redmile Group, LLC transactions in Ac Immune Sa stock. As of the latest transaction made, Redmile Group, LLC holds 1,807,704 shares of ACIU stock, worth $5.31 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares
1,807,704
Previous 2,007,031 9.93%
Holding current value
$5.31 Million
Previous $5.94 Million 21.41%
% of portfolio
0.47%
Previous 0.23%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$2.29 - $4.87 $456,458 - $970,722
-199,327 Reduced 9.93%
1,807,704 $7.21 Million
Q1 2024

May 15, 2024

BUY
$2.66 - $4.87 $18,702 - $34,240
7,031 Added 0.35%
2,007,031 $5.94 Million
Q4 2023

Feb 14, 2024

BUY
$2.46 - $5.0 $4.92 Million - $10 Million
2,000,000 New
2,000,000 $10 Million

Others Institutions Holding ACIU

About AC Immune SA


  • Ticker ACIU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,413,504
  • Market Cap $245M
  • Description
  • AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...
More about ACIU
Track This Portfolio

Track Redmile Group, LLC Portfolio

Follow Redmile Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmile Group, LLC with notifications on news.